New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic
DOAC therapy showed equal efficacy in the long-term treatment of pulmonary embolism in both study groups, regardless of whether the subjects had COVID-19 or not.
Authors
- Elma Kuduzović
- Amar Terzimehic
- Muhamed Skomorac
- Lejla Hindija
Institutions
- University of Zenica (BA)
- Vetenskap I Skolan (SE)
Publication Details
- Journal
- Materia Socio Medica
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5455/msm.2025.37.144-148
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00